Martine Chamuleau

Interested to hear about the Burkitt Lymphoma Network activities and news? Join us Friday 8th 6-8 pm at #ASH23. Sign up via info@burkitt-lymphoma.org. See the exiting program below and more at burkitt-lymphoma.org.

Results of the randomized phase 3 study comparing DA-EPOCH-R vs R-CODOX-M/R-IVAC for #burkitt lymphoma patients are online in Lancet Haematology. Proud of our contribution to better quality-of-life for patients and more efficiency in health care! authors.elsevier.com/a/1i0Qu_rV3GEO…

@SMbulaiteye Thanks Sam, we won’t forget them!! Hope to meet you next time!

This is great! My hope is that Africa and African patients will NOT be left behind!

Today, the international Burkitt Lymphoma Network has been launched at #ASH22! Thanks @lymphomatic (Adam Olszewski), @DrLaCasce for co-chairing and @morinryan,@DunleavyKieron ,@Josef-Maria Ribera for nice overviews and all participants for sharing new concepts!

Just 2 days before we launch the International Burkitt Lymphoma Network on Dec 9th at #ASH22! Let’s use global cooperation to improve outcome for patients with this disease! For information on the program see www. Burkitt-lymphoma.org #lymphoma, #ASH_hematology, #Burkitt

@JuanAlderuccio @EHA_Hematology Looking forward to present the data on Sumday in the Late Breaking Session!

Although HOVON study closed prematurely due to slow accrual, these preliminary results demonstrate comparable OS between arms in Burkitt #lymphoma. Looking forward to this presentation and more mature data. #EHA2022 @EHA_Hematology library.ehaweb.org/eha/2022/eha20…

@mvdweijden; Maarten Gefeliciteerd! Herinner me als de dag van gisteren dat ik jou (en je moeder) in @amsterdamumc vertelde dat je acute leukemie had.... Wat een held was en ben je!!